Anthony Romer
About Anthony Romer
Anthony Romer serves as the Associate Director of Stem Cell Research & Development at ElevateBio, where he focuses on engineering stem cell-derived beta cells for diabetes treatment. He has extensive experience in stem cell research, having previously held positions at Dana-Farber Cancer Institute, Sigilon Therapeutics, and Columbia University.
Work at ElevateBio
Anthony Romer currently serves as the Associate Director of Stem Cell Research & Development at ElevateBio, a position he has held since 2022. In this role, he focuses on engineering stem cell-derived beta cells with the potential to cure various forms of diabetes. His work involves collaboration with experts in immunology, computational biology, genetics, and bioengineering to create immune-tolerant, teratoma-free stem cell-derived cells. His contributions are aimed at advancing the field of regenerative medicine.
Previous Experience at Dana-Farber Cancer Institute
Prior to his current role, Anthony Romer worked at Dana-Farber Cancer Institute as a Research Assistant from 2002 to 2005. During his three years in the Greater Boston Area, he gained valuable experience in cancer research, contributing to the institute's mission of advancing cancer treatment and understanding.
Experience at Sigilon Therapeutics, Inc.
Anthony Romer held the position of Senior Research Scientist at Sigilon Therapeutics, Inc. from 2018 to 2020 in Cambridge, MA. In this role, he focused on innovative approaches to cell therapy, contributing to the development of new therapeutic strategies aimed at treating various diseases.
Education and Expertise
Anthony Romer earned his Bachelor of Science degree in Biochemistry from the University of Wisconsin-Madison, where he studied from 1998 to 2002. He then pursued a Ph.D. in Biomedical Sciences at the Icahn School of Medicine at Mount Sinai, completing his studies from 2005 to 2012. Additionally, he served as a Postdoctoral Research Fellow at Columbia University from 2012 to 2016, followed by a role as Associate Research Scientist and Fellow in Precision Medicine from 2016 to 2018.
Research Focus and Interests
Anthony Romer's research is centered on developing scalable and high-quality stem cell-derived cells for the treatment of cardiovascular, neurological, and metabolic diseases. He aims to engineer stem cell-derived beta cells to address diabetes and collaborates with various specialists to enhance the efficacy and safety of stem cell applications in medicine.